Taken together, these results suggest that the strength of connectivity between hippocampus and downstream regions is modulated by the degree of baseline AD pathology to predict tau accumulation, and the interactions between these factors have the potential to explain differences in rates and distribution of tau accumulation at the earliest stages of cognitive impairment. This evidence concerns the gene MAPT and Alzheimer disease.